Medicare Enrolled
Dr. Rajina Ranadive, MD
Internal Medicine · Petaluma, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ranadive from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ranadive?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ranadive
Dr. Rajina Ranadive is an internal medicine specialist in Petaluma, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ranadive performed 5,938 Medicare services across 1,810 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ranadive received a total of $4,844 from 40 pharmaceutical and/or device companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ranadive is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$4,844 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,938
Medicare services
Top 5% in CA for internal medicine
1,810
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~313 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,420 | $18 | $34 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
723 | $91 | $345 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
256 | $122 | $351 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
254 | $140 | $354 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
177 | $10 | $32 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
143 | $140 | $485 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
129 | $92 | $345 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
122 | $35 | $112 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
96 | $142 | $430 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
88 | $13 | $39 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
84 | $29 | $30 |
| Annual depression screening | 80 | $21 | $51 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
69 | $76 | $133 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
63 | $90 | $239 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
41 | $46 | $144 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
36 | $75 | $245 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
33 | $17 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $66 | $245 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
24 | $2 | $10 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
22 | $29 | $30 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
20 | $280 | $567 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
15 | $3 | $10 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
11 | $64 | $74 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,844
Total received (2018-2024)
Avg $692/year across 7 years
Top 16% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
276
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,624 (95.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$200 (4.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$27
2023
$941
2022
$338
2021
$659
2020
$940
2019
$1,115
2018
$824
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$27
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,020
Novo Nordisk Inc
$452
Allergan Inc.
$441
PFIZER INC.
$301
ABBVIE INC.
$219
Astellas Pharma US Inc
$217
Radius Health, Inc.
$207
Boehringer Ingelheim Pharmaceuticals, Inc.
$194
GlaxoSmithKline, LLC.
$168
Merck Sharp & Dohme Corporation
$165
Lilly USA, LLC
$125
Janssen Pharmaceuticals, Inc
$122
AstraZeneca Pharmaceuticals LP
$121
Insulet Corporation
$89
Teva Pharmaceuticals USA, Inc.
$88
AbbVie Inc.
$83
E.R. Squibb & Sons, L.L.C.
$82
Sunovion Pharmaceuticals Inc.
$64
ITI, Inc.
$64
Allergan, Inc.
$63
Sumitomo Pharma America, Inc.
$59
Scilex Pharmaceuticals Inc.
$56
Edwards Lifesciences Corporation
$46
Biogen, Inc.
$44
Synergy Pharmaceuticals Inc
$40
SANOFI PASTEUR INC.
$36
iRhythm Technologies, Inc.
$35
Eisai Inc.
$31
Boston Scientific Corporation
$27
Sanofi Pasteur Inc.
$26
Otsuka America Pharmaceutical, Inc.
$18
Shire North American Group Inc
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
ACADIA Pharmaceuticals Inc
$17
Kowa Pharmaceuticals America, Inc.
$17
Phadia US Inc.
$16
SANOFI-AVENTIS U.S. LLC
$14
Circassia Pharmaceuticals Inc
$14
Biohaven Pharmaceuticals, Inc.
$12
Biohaven Pharmaceutical Holding Company Ltd.
$12
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · ANORO · AREXVY · Aimovig · BREZTRI · BYSTOLIC · CAPLYTA · DUAKLIR PRESSAIR · Dayvigo · ELIQUIS · EMGALITY · EUCRISA · EVENITY · Edwards SAPIEN 3 Transcatheter Heart Valve · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · GARDASIL 9 · GEMTESA · GENERAL PAIN MANAGEMENT · ImmunoCAP · JANUVIA · JARDIANCE · KAPSPARGO · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · NATPARA · NO PRODUCT DISCUSSED · NUPLAZID · NURTEC ODT · Omnipod · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QVAR · REXULTI · Repatha · Rybelsus · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TRELEGY ELLIPTA · TRULICITY · Trulance · Tymlos · UBRELVY · VIBERZI · VIIBRYD · VRAYLAR · Veozah · Victoza · XARELTO · ZIO Patch · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
540
Per 100K population
111.2
County median income
$102,840
Nearest hospital
PETALUMA VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ranadive is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ranadive experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Ranadive performed 3,420 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ranadive receive payments from pharmaceutical companies?
Yes. Dr. Ranadive received a total of $4,844 from 40 companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ranadive's costs compare to other internal medicine physicians in Petaluma?
Dr. Ranadive's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ranadive) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Petaluma
Browse internal medicine physicians in Petaluma ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology